| [1] |
Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality[J].Breast Cancer Res,2004,6(6):229-239.
|
| [2] |
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980:systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants[J]. Lancet,2011,377(9765):557-567.
|
| [3] |
Morimoto LM,White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) [J]. Cancer Cause Control,2002,13(8):741-751.
|
| [4] |
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies[J]. Lancet,2008,371(9612):569-578.
|
| [5] |
李泓澜, 高玉堂, 李奇,等. 身体测量指标与女性乳腺癌关系的前瞻性队列研究[J]. 中国流行病学杂志, 2006,27(6):488-493.
|
| [6] |
Stark A, Stahl MS, Kirchner HL, et al. Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast:findings from a case-series study[J]. Int J Obes (Lond),2010,34(9):1381-1386.
|
| [7] |
Ewertz M, Jensen MB, Gunnarsdottir KA, et al. Effect of obesity on prognosis after early-stage breast cancer[J]. J Clin Oncol,2011,29(1):25-31.
|
| [8] |
Daling JR, Malone KE, Doody DR, et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma[J]. Cancer,2001,92(4):720-729.
|
| [9] |
Gillespie EF, Sorbero ME, Hanauer DA, et al. Obesity and angiolymphatic invasion in primary breast cancer[J]. Ann Surg Oncol,2010,17(3):752-759.
|
| [10] |
Vona-Davis L, Rose DP, Hazard H, et al. Triple-negative breast cancer and obesity in a rural Appalachian population[J]. Cancer Epidemiol Biomarkers Prev,2008,17(12):3319-3324.
|
| [11] |
Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women[J]. J Natl Cancer Inst,2003,95(16):1218-1226.
|
| [12] |
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer[J]. N Engl J Med,2006,354(3):270-282.
|
| [13] |
Planas-Silva MD, Waltz PK, Kilker RL. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant[J]. J Steroid Biochem Mol Biol,2006,98(4/5):193-198.
|
| [14] |
O'Neill JS, Elton RA, Miller WR. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site[J]. Br Med J (Clin Res Ed),1988,296(6624):741-743.
|
| [15] |
Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance[J]. Diabetes Care,2001,24(3):588-597.
|
| [16] |
Lang CH, Fan J, Frost RA, et al. Regulation of the insulin-like growth factor system by insulin in burn patients[J]. J Clin Endocrinol Metab,1996,81(7):2474-2480.
|
| [17] |
Tang X, Zhang Q, Shi S, et al. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells[J]. Int J Cancer,2010,126(1):90-103.
|
| [18] |
Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults[J].JAMA,1999,282(22):2131-2135.
|
| [19] |
Neels JG, Olefsky JM. Inflamed fat: what starts the fire? [J]. J Clin Invest,2006,116(1):33-35.
|
| [20] |
Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients[J]. Br J Cancer,2003,88(11):1721-1726.
|
| [21] |
Catalano S, Marsico S, Giordano C, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line[J]. J Biolog Chem,2003,278(31):28 668-28 676.
|
| [22] |
Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro[J]. Exp Mol Med,2001,33(2):95-102.
|
| [23] |
Wang Y, Lam JB, Lam KS, et al. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice[J]. Cancer Res, 2006, 66(23):11 462-11 470.
|
| [24] |
Motoshima H, Goldstein BJ, Igata M, et al. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer[J]. J Physiol,2006,574(Pt1):63-71.
|
| [25] |
Brown KA, McInnes KJ, Hunger NI, et al. Subcellular localization of cyclic AMP-responsive element binding proteinregulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women[J].Cancer Res,2009,69(13):5392-5399.
|
| [26] |
Griggs JJ, Sorbero ME, Lyman GH. Undertreatment of obese women receiving breast cancer chemotherapy[J]. Arch Intern Med,2005,165(11):1267-1273.
|
| [27] |
Sestak I, Distler W, Forbes JF, et al. Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial[J]. J Clin Oncol,2010,28(21):3411-3415.
|
| [28] |
Kroenke CH, Chen WY, Rosner B, et al. Weight, weight gain, and survival after breast cancer diagnosis[J]. J Clin Oncol,2005,23(7):1370-1378.
|
| [29] |
高艳, 曹水, 任秀宝, 等. 肥胖对淋巴结阳性的乳腺癌患者总生存率的影响[J]. 肿瘤,2010,30(11):960-964.
|
| [30] |
Jen KL, Djuric Z, DiLaura NM, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens[J]. Obes Res,2004,12(2):306-312.
|
| [31] |
Holmes MD, Chen WY, Feskanich D, et al. Physical activity and survival after breast cancer diagnosis[J]. JAMA,2005,293(20):2479-2486.
|